aromasil has been researched along with Mesothelioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briganti, S; Camera, E; Galati, R; Mastrofrancesco, A; Nuvoli, B | 1 |
| Cordone, I; Cortese, G; Galati, R; Germoni, S; Masi, S; Morosetti, C; Nuvoli, B; Santoro, R | 1 |
| Baldi, A; Biroccio, A; D'Angelo, C; Galati, R; Muti, P; Sacchi, A; Salvatori, L; Stoppoloni, D; Verdina, A; Vincenzi, B | 1 |
3 other study(ies) available for aromasil and Mesothelioma
| Article | Year |
|---|---|
Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane.
Topics: Acetylcysteine; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Asbestos; Cell Death; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Environmental Exposure; Extracellular Signal-Regulated MAP Kinases; Humans; Mesothelioma; Oxidative Stress; Pleural Neoplasms; Reactive Oxygen Species; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; STAT3 Transcription Factor; Treatment Outcome | 2018 |
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
Topics: Androstadienes; Animals; Aromatase Inhibitors; Cell Proliferation; Cisplatin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Xenograft Model Antitumor Assays | 2014 |
Aromatase inhibitor exemestane has antiproliferative effects on human mesothelioma cells.
Topics: Androstadienes; Aromatase; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Follow-Up Studies; Humans; Immunoenzyme Techniques; Mesothelioma; Prognosis; Receptors, Estrogen; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tumor Cells, Cultured | 2011 |